DRUG STIMULATED BIOTRANSFORMATION OF HORMONAL STEROID CONTRACEPTIVES - CLINICAL IMPLICATIONS

被引：41
|
作者：
HEMPEL, E
KLINGER, W
机构：
[1] FRIEDRICH SCHILLER UNIV,DEPT GYNECOL & OBSTET,DDR-69 JENA,GER DEM REP
[2] FRIEDRICH SCHILLER UNIV,INST PHARMACOL & TOXICOL,DDR-69 JENA,GER DEM REP
来源：
DRUGS | 1976年 / 12卷 / 06期
关键词：
D O I：
10.2165/00003495-197612060-00003
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：442 / 448
页数：7
相关论文
共 50 条
  • [31] A translational approach to study drug-drug interaction with hormonal contraceptives: From Pharmacoepidemiology to mechanistic modeling
    Sarayani, Amir
    Cicali, Brian
    Schmidt, Stephan
    Brown, Joshua
    Winterstein, Almut
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 108 - 108
  • [32] Prescribing Hormonal Contraceptives to Women on Antiepileptic Drugs: Assessing Compendia Reporting of Drug-Drug Interactions
    Acton, Emily K.
    Decker, Barbara M.
    Willis, Allison W.
    ANNALS OF NEUROLOGY, 2019, 86 : S70 - S71
  • [33] Risk of thrombosis associated with drug-drug interactions between oral hormonal contraceptives and verapamil or diltiazem
    Desai, Raj A.
    Thai, Thuy N.
    Pham, Phoung N.
    Schmidt, Stephan
    Winterstein, Almut
    Brown, Joshua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 403 - 403
  • [34] The clinical implications of steroid receptor coactivators
    Smith, Carolyn
    HORMONE RESEARCH, 2006, 65 : 8 - 8
  • [35] Pre-clinical and early clinical considerations for the development of non-hormonal contraceptives for men
    Johnston, Daniel S.
    ANDROLOGY, 2024, 12 (07) : 1558 - 1567
  • [36] Clinical pharmacokinetic interactions between lamotrigine and hormonal contraceptives in bipolar I disorder
    Sawagashira, Ryo
    Fujii, Yutaka
    Kusumi, Ichiro
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2017, 71 (04) : 290 - 290
  • [37] CLINICAL AND HORMONAL EFFECTS OF 2 CONTRACEPTIVES - CORRELATION TO SERUM CONCENTRATIONS OF LEVONORGESTREL AND GESTODENE
    REFN, H
    KJAER, A
    LEBECH, AM
    BORGGAARD, B
    SCHIERUP, L
    CONTRACEPTION, 1990, 41 (03) : 259 - 269
  • [38] The impact of hormonal contraceptives on anxiety treatments: From preclinical models to clinical settings
    Graham, Bronwyn M.
    FRONTIERS IN NEUROENDOCRINOLOGY, 2022, 67
  • [39] COST IMPLICATIONS OF DRUG-DRUG INTERACTIONS WITH HORMONAL CONTRACEPTIVES: A CONCEPTUAL FRAMEWORK BASED ON LINKED PHARMACOKINETIC-PHARMACODYNAMIC-PHARMACOECONOMIC (PK-PD-PE) MODELS
    Srinivasan, M.
    White, A.
    Chaturvedula, A.
    Schmidt, S.
    Adunlin, G.
    Wingate, L. T.
    VALUE IN HEALTH, 2019, 22 : S184 - S185
  • [40] Confirmation of the drug-drug interaction potential between cobicistat-boosted antiretroviral regimens and hormonal contraceptives
    Majeed, Sophia R.
    West, Steve
    Ling, Kah Hiing
    Das, Moupali
    Kearney, Brian P.
    ANTIVIRAL THERAPY, 2019, 24 (08) : 557 - 566
12345